PMID: 2117202Jan 1, 1990Paper

Modern treatment of pulmonary embolism

Lung
C M Kessler

Abstract

Pulmonary embolism is diagnosed over 100,000 times yearly in the United States and is the recognized primary cause of death in at least 10,000 cases. Thrombolytic therapy has been successful in reducing clot burden substantially; however, clinical data are lacking to indicate that thrombolytic therapy improves mortality rates in patients with pulmonary emboli or that the pharmacologic removal of clot will improve future quality of life. The use of thrombolytic agents has been limited by the potential for producing hemorrhagic complications. This paper discusses the pharmacology of numerous thrombolytic agents and their clinical use in research studies intended to determine the safest and most efficacious regimens. Recombinant t-PA infusions appear quite safe and produce very rapid lyses of pulmonary emboli. Innovative administration regimens of urokinase also appear promising. The availability of extremely safe and efficacious treatment regimens should allow for large epidemiologic studies to be conducted to determine whether thrombolytic therapy will improve the morbidity and mortality of pulmonary embolism.

References

Apr 1, 1989·Mutation Research·K L Dearfield, C O Abernathy
Oct 18, 1986·Lancet·S Z GoldhaberG V Sharma
Dec 1, 1988·Journal of Cellular Biochemistry·S Z GoldhaberP C Come
Apr 4, 1985·The New England Journal of Medicine·UNKNOWN TIMI Study Group
Jul 1, 1973·The Journal of Clinical Investigation·S NiewiarowskiP Gillies

❮ Previous
Next ❯

Citations

Mar 29, 2002·Chemistry : a European Journal·Michael HermThomas Schrader
Apr 25, 2001·Journal of Addictive Diseases·E T MoolchanD Epstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.